Credit Suisse is out today with a "fat" report on obesity. Nearly 200 pages. But besides its size, the research also stands out as one of the most unique pieces of Wall Street analysis I've ever seen.
The firm assembled what it calls the "Obesity Team" made up not just of healthcare analysts, but also a whole bunch of consumer products analysts: 21 people in all.
The result is a comprehensive report that goes way beyond identifying all of the usual suspects in fat-fighting biopharmas for investors. It points out all sorts of somewhat counterintuitive investment ideas that could play a role in the obesity space that the team calls "The Credit Suisse Healthier 15." So, here are the stocks that made the cut: